News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Paolo Tarantino: No statistical improvement in OS with the Trop2 ADC SG vs TPC in met urothelial cancer
Paolo Tarantino/X
Feb 14, 2025, 09:48

Paolo Tarantino: No statistical improvement in OS with the Trop2 ADC SG vs TPC in met urothelial cancer

Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, shared a paper Tom Powles and his colleagues authored on X:

“TROPiCS-04 trial out on Annals of Oncology: no statistical improvement in OS with the Trop2 ADC SG vs TPC in met urothelial cancer, with higher rate of G5 AEs with SG. Led to the withdrawal of SG approval for mUC. No association between Trop2 exp and SG activity.”

Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial

Authors: Thomas Powles et al.

Paolo Tarantino

A. Necchi C. Vulsteke C.N. Sternberg C.S. Sima cancer F. Boateng I. Durán J. Bellmunt J. Guo J. Waldes L. Wang M. De Santis M. Gross-Goupil M. Kovalenko M. Sierecki OncoDaily Oncology P. Grivas P.J. Goebell Paolo Tarantino R. Morales-Barrera S. Tagawa S.H. Park T. Powles Y. Loriot
Special Coverage
Science
Feb 18, 2025, 19:35
Elizabeth McKenna: High Glucose Contribution to the Non–Small Cell Lung Cancer Patients
Blog
Feb 18, 2025, 19:32
Sabine D. Brookman-May: Updated analysis with additional FU of EV 302 in 1st line advanced Bladder Cancer
Blog
Feb 18, 2025, 19:27
The International Urology Cancer Summit 2025 will take place in Portsmouth
Science
Feb 18, 2025, 19:16
Ana Carolina Izurieta Pacheco: Global perspective on childhood cancer survivorship care in limited resource settings
Science
Feb 18, 2025, 19:12
Yan Leyfman: New Research on Trogocytosis in CAR-T Cells
Science
Feb 18, 2025, 19:03
Douglas Flora: Turning AI into a world-class medical detective
Science
Feb 18, 2025, 18:55
Herbert Loong: Wong King Ho - a wonderful collaborator throughout the years
Science
Feb 18, 2025, 18:35
Giannis Mountzios: Biomarker-selected or biomarker-agnostic ADCs for oncogene-addicted NSCLC
Science
Feb 18, 2025, 18:13
Sebastian Schmidt: Lung cancer screening in smokers and non-smokers
Blog
Feb 18, 2025, 17:57
Wafaa M Rashed: PAPERI Bright Minds with Ruth Nanjala
Blog
Feb 18, 2025, 17:36
Sabine Brookman-May: Elevated CXCR4 expression in MIBC in vitro
Blog
Feb 18, 2025, 17:29
Paolo Tarantino: SGBCC 2025 - an unmissable event for those involved in breast oncology